Baird Investment Banking Adds Adam Huitt to Global Healthcare Team, Expands Global Pharmaceutical Services Coverage
CHARLOTTE, N.C. – Oct. 29, 2020 – Baird, an employee-owned, international financial services firm, announced today that Adam Huitt has joined the firm’s Global Investment Banking business as Managing Director on its Global Healthcare Investment Banking team. Huitt will partner with senior investment banker Ben Brown and other members of Baird’s Global Healthcare Investment Banking team to further enhance the firm’s coverage of the pharmaceutical services and related sectors, including multiple vertical markets ranging from drug research, development and manufacturing to lab services and distribution. He will be based out of the firm’s Charlotte office.
Huitt most recently served as Managing Director at BlackArch Partners where he headed the Healthcare industry practice since 2017. Prior to BlackArch, Adam was a senior member of the Healthcare Investment Banking group at Wells Fargo Securities, where he focused on pharmaceutical and healthcare services for over a decade. Prior to Wells Fargo, he worked in strategy and operational roles for Hewlett-Packard Company and Eaton Corporation. He holds an MBA from Duke University’s Fuqua School of Business, a master’s degree in mechanical engineering from The Georgia Institute of Technology and a bachelor’s degree in mechanical engineering from Virginia Commonwealth University.
“We are thrilled that Adam has decided to continue his career at Baird,” said Rob Andrews, Co-Head of Baird Global Healthcare Investment Banking. “He brings a wealth of healthcare industry knowledge and transaction experience that will complement our healthcare investment banking practice and strengthen our overall offering to our global clients.”
Bill Suddath, Co-Head of Baird Global Healthcare Investment Banking, added: “Adam’s addition to the team is another exciting development for our Global Healthcare practice, demonstrating Baird’s commitment to delivering deep healthcare sector knowledge, thought leadership and transaction expertise to our clients. Together, Adam, Ben and the rest of the team covering the pharmaceutical services and IT segment will bring a comprehensive scope of experience and relationships to serve the global pharmaceutical and medical products market.”
Baird’s Global Healthcare platform has been adding top talent and experiencing strong deal flow momentum despite the challenges of COVID-19. Huitt is the third senior banker to join the firm’s Global Healthcare platform within the past two years. Early this month, Baird added Andrew Nicholson in London to lead healthcare coverage in Europe. In July of 2019, Baird added Jason Porter in Charlotte to cover physician and alternate site healthcare services.
“It’s an exciting time to be joining Baird’s growing global healthcare platform,” said Huitt. “As part of this hardworking, results-driven team I look forward to delivering the best possible outcomes for our investment banking clients through Baird’s extensive capabilities, deep industry expertise and global reach.”
Baird’s Global Healthcare platform includes 40 investment bankers, who have completed 150 healthcare M&A and financing transactions since 2017; 19 Equity Research Analysts covering nearly 150 healthcare stocks; and a dedicated Equity Sales & Trading team that makes a market in approximately 600 healthcare stocks and has traded more than 650 million shares of those stocks in the last twelve months. Baird also recently hosted its annual Healthcare conference. Although it was in a virtual format this year, the conference featured more than 135 presenting companies, 1,700 attendees and 2,300 one-on-one meetings.
About Baird Global Investment Banking
Baird is a leading global investment bank focused on the middle market with nearly 350 banking professionals in the U.S., Europe and Asia. We provide corporations, entrepreneurs, private equity and venture capital firms with in-depth market knowledge and extensive experience in merger and acquisition, debt advisory and equity financing transactions. Since 2015, Baird has completed almost 580 advisory transactions, representing more than $167 billion in transaction value, and nearly 360 financings, raising more than $112 billion. Committed to being a great place to work, Baird ranked No. 13 on FORTUNE’s 100 Best Companies to Work For in 2020 – its 17th consecutive year on the list.
Putting clients first since 1919, Baird is an employee-owned, international wealth management, asset management, investment banking/capital markets, and private equity firm with offices in the United States, Europe and Asia. Baird has approximately 4,600 associates serving the needs of individual, corporate, institutional and municipal clients and more than $305 billion in client assets as of December 31, 2019. Committed to being a great workplace, Baird ranked No. 13 on the 2020 Fortune 100 Best Companies to Work For® list. Baird is the marketing name of Baird Financial Group. Baird’s principal operating subsidiaries are Robert W. Baird & Co. Incorporated in the United States and Robert W. Baird Group Ltd. in Europe. Baird also has an operating subsidiary in Asia supporting Baird’s investment banking and private equity operations. For more information, please visit Baird’s website at www.rwbaird.com.
For additional information, contact:
Baird Public Relations